Gebizid TZ 250mg/31.25mg Injection
Marketer
Oddiant Formulations
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Gebizid TZ 250mg/31.25mg Injection
Tazobactam and Cefixime Injection (250mg/31.25mg) is a dual-action antibiotic. This medication combats diverse bacterial infections by hindering microbial proliferation and preventing infection spread. Administration must be solely under medical guidance. Strictly adhere to your prescribed dosage schedule; completing the entire course is vital, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before initiating treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may conduct tests to monitor the medication's impact.
Primary Ingredients of Gebizid TZ 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Gebizid TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Gebizid TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Gebizid TZ 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Gebizid TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Gebizid TZ 250mg/31.25mg Injection works:
Gebizid TZ 250mg/31.25mg Injection combines the antibiotic ceftazidime with the beta-lactamase inhibitor tazobactam. Ceftazidime disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counters bacterial resistance mechanisms, thereby boosting ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Gebizid TZ 250mg/31.25mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Gebizid TZ 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Gebizid TZ 250mg/31.25mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
The injection Gebizid TZ 250mg/31.25mg can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Gebizid TZ 250mg/31.25mg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Gebizid TZ 250mg/31.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Gebizid TZ 250mg/31.25mg Injection :
Omit a Gebizid TZ 250mg/31.25mg Injection dose? Seek medical advice immediately.
Facts to Know About Gebizid TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently